CERVICAL CANCER SCREENING: COMPARISON BETWEEN THE PAPANICOLAOU TEST AND HPV DNA TESTING
DOI:
https://doi.org/10.51891/rease.v12i11.32291Keywords:
Papanicolaou, DNA-HPV, NeoplasmsAbstract
Cervical cancer represents a major public health concern, highlighting the importance of improving screening and early detection strategies. This study aimed to analyze the evolution of cervical cancer screening methods by comparing the Papanicolaou cytological examination and molecular HPV DNA tests regarding their applications, advantages, and limitations. This study consists of a narrative literature review with a qualitative, descriptive, and analytical approach, based on searches conducted in the SciELO, Virtual Health Library (VHL), and PubMed databases, considering publications from 2022 to 2026. The studies analyzed highlighted the historical importance of the Papanicolaou test, particularly due to its accessibility and low cost, although it presents limitations related to sensitivity and the possibility of false-negative results. In contrast, molecular tests demonstrated greater sensitivity in identifying high-risk HPV infections, contributing to improvements in screening strategies. It is concluded that the use of HPV DNA testing as a primary screening method, with cytology as one of the possible triage strategies for positive cases, represents a relevant approach to cervical cancer prevention, considering challenges related to access, infrastructure, and professional training.
Downloads
Downloads
Published
Issue
Section
Categories
License
Atribuição CC BY